Zygomycosis clinical trials
The registry lists 3 studies for Zygomycosis across 3 countries. 0 are recruiting or about to start. 1 of them are mainly about Zygomycosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-05-22. Counting its narrower condition Mucormycosis too: 33 studies, 8 open.
Who runs them
Assistance Publique - Hôpitaux de Paris (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center (1)
What is being tested here
Drugs under test in Zygomycosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Posaconazole | 0 | 0 | 1 |
| Liposomal amphotericin B | 0 | 0 | 1 |
| Amphotericin B | 0 | 0 | 1 |
| Deferasirox | 0 | 0 | 1 |
Who these studies take
No Zygomycosis study is recruiting now.
Across all 3 studies, recruiting or not: 0% stop at 75 or younger and 0% at 65; 100% take children; 0% are for women only and 0% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. search them.
- Amphotericin Versus Posaconazole for Pulmonary MucormycosisCompletedNCT05468372Phase 21 country
- Pilot Study of High Dose Liposomal Amphotericin B Efficacy in Initial Zygomycosis TreatmentCompletedNCT00467883Phase 21 country
- The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyCompletedNCT00419770Phase 21 country